✦ LIBER ✦
Effect of a monoclonal antibody to PCSK9, REGN727/SAR236553, to reduce low-density lipoprotein cholesterol in patients with heterozygous familial hypercholesterolaemia on stable statin dose with or without ezetimibe therapy: a phase 2 randomised controlled trial
✍ Scribed by Evan A Stein; Dan Gipe; Jean Bergeron; Daniel Gaudet; Robert Weiss; Robert Dufour; Richard Wu; Robert Pordy
- Book ID
- 117310345
- Publisher
- The Lancet
- Year
- 2012
- Tongue
- English
- Weight
- 258 KB
- Volume
- 380
- Category
- Article
- ISSN
- 0140-6736
No coin nor oath required. For personal study only.